Journal of Allergy & Therapy

Cheryl S Hankin

Cheryl S Hankin, PhD
President and Chief Scientific Officer, Health Economics and Outcomes Research
USA

Biography

Dr Cheryl Hankin is a respected leader in health economics and outcomes research for the pharmaceutical biotech health care device medical informatics and drug delivery industries She graduated from Wellesley College with highest academic honors Wellesley College Scholar before earning her doctorate in clinical psychology from Pacific Graduate School of Psychology and completing dual postdoctoral fellowships in Health Services Research and Gerontology at the Department of Veterans Affairs Health Services Research and Development Centers of Excellence Dr Hankin is President and Chief Scientific Officer of BioMedEcon LLC Her passion to affect positive change in healthcare is the driving force behind the success of BioMedEcon Dr Hankin’s experience in Health Economics and Outcomes Research spans the health care industry Director of Outcomes Research at Johnson and Johnson companies academia Assistant Professor at Boston University School of Public Health and the public sector Research Health Scientist at the Department of Veterans Affairs Health Services Research and Development Center of Excellence She has authored and delivered over 150 peerreviewed publications and presentations

Research Interest

She is currently conducting research on the comparative effectiveness of allergen immunotherapy. This research is supported by joint funding from the American Academy of Allergy, Asthma and Immunotherapy and the American College of Allergy, Asthma and Immunology. Dr. Hankin's recently published articles in Journal of Allergy and Clinical Immunology and Annals of Allergy, Asthma & Immunology provide examples of this research.